High incidence of CDA deficiency in patients with hematological malignancies: perspectives and therapeutic implications

M. Donnette (1) , J. Ciccolini (1) , C. Pissier (2) , R. Costello (3) , F. Duffaud (4) , S. Salas (4) , L. Farnault (3) , A. Tichadou (3) , R. Arcani (5) , P.A. Jarrot (5) , L.H. Ouafik (6, 2) , G. Venton (3) , R. Fanciullino (1) , L'Houcine Ouafik

1 SMARTc - Simulation and Modeling of Adaptive Response for Therapeutics in Cancer
2 Laboratoire de Transfert d'Oncologie Biologique [Hôpital Nord - APHM]
3 LA CONCEPTION - Hôpital de la Conception [CHU - APHM]
4 Service d’Oncologie Médicale [Hôpital de la Timone - APHM]
5 Médecine interne et immunologie clinique [Hôpital de la Conception - APHM]
6 INP - Institut de neurophysiopathologie

Domaines: Cancer

M. Donnette, J. Ciccolini, C. Pissier, R. Costello, F. Duffaud, et al.. High incidence of CDA deficiency in patients with hematological malignancies: perspectives and therapeutic implications. Annals of Oncology, 2021, 32 (5), pp.684-686. ⟨10.1016/j.annonc.2021.01.072⟩. ⟨hal-03279253⟩